Document is current
Any future updates will be listed below
-
Authors
Bade, Aditya N. https://orcid.org/0000-0003-2511-4461
McMillan, JoEllyn M.
Liu, Yutong
Edagwa, Benson J.
Gendelman, Howard E. https://orcid.org/0000-0002-7831-0370
-
Funding
Funding for this research was provided by:
national institutes of health (P01 DA028555)
national institutes of health (P01 DA028555-09S1)
national institutes of health (R01 NS36126)
national institutes of health (R01 MH121402)
national institutes of health (P30 MH062261)
national institutes of health (R01 MH115860)
national institutes of health (2R01 NS034239)
national institutes of health (R01 AI158160)
national institutes of health (R01AI145542)
bioimaging core (mri) grant from the nebraska center for nanomedicine
- License Information
-
More Information
Article History
Received: 14 June 2021
Accepted: 25 July 2021
First Online: 14 August 2021
Declarations
:
: All animal studies were approved by the University of Nebraska Medical Center Institutional Animal Care and Use Committee (IACUC) in accordance with the standards incorporated in the Guide for the Care and Use of Laboratory Animals (National Research Council of the National Academies, 2011).
: Not applicable.
: Not applicable.
: Drs. Benson Edagwa and Howard E. Gendelman are co-founders of Exavir Therapeutics, Inc., a biotechnology company focused on the development of long-acting antiretroviral medicines. The remaining authors declare that they have no competing interests.
